Breast cancer detection in relation to oral contraception.
Analyses of tumor size and breast cancer stage were used to determine whether biased detection of breast cancer could have materially influenced estimates of risk associated with use of oral contraceptives. In a population-based case-control study conducted from 1980-1982, surveillance for breast cancer by breast exams, but not mammography, was found to be strongly linked to use of oral contraceptives. Tumors were slightly smaller and less likely to be late-stage (TNM stage III or IV) in patients who had used oral contraceptives. The net effect of any diagnostic bias on advancing the date of cancer diagnosis, whether from breast exams or other sources, was estimated to be less than 8 weeks. This corresponds to spuriously increasing the risk of early-occurring breast cancer in oral contraceptive users by at most 2.4% (relative risk = 1.024).
Schlesselman
J J
JJ
Department of Preventive Medicine & Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814.
Stadel
B V
BV
Korper
M
M
Yu
W
W
Wingo
P A
PA
D000328:Adult; D000367:Age Factors; D015982:Bias; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D016022:Case-Control Studies; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008327:Mammography; D008593:Menopause; D008875:Middle Aged; D012307:Risk Factors; D016353:Self-Examination; D013997:Time Factors
D003276:Contraceptives, Oral